• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Oncology

Pleural effusions associated with worse survival in non-small-cell lung cancer

byMonica ParksandAndrew Bishara
February 21, 2014
in Oncology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. Pleural effusions were associated with worse survival in non-small-cell lung cancer (NSCLC), particularly when they arose in early stage disease.

Evidence rating level: 2 (Good)

Study Rundown: Malignant pleural effusion containing malignant cells helps to define metastatic staging of lung cancer; however, diagnostic thoracentesis and pleural biopsy are not recommended for minimal effusions of <10mm thickness. Therefore, minimal pleural effusions are not currently included in the staging of small-cell or non-small-cell lung cancer. The purpose of this study was to evaluate the relationship between minimal effusion and survival. Upon survival analysis of a large retrospective cohort, the authors found that a minimal pleural effusion was significantly associated with shorter survival time, particularly in early stage disease.

This study benefits from the large population enrolled and consideration of many potential prognostic variables. However, due to the retrospective nature of this study, many other potentially significant variables such as environmental factors could not be controlled for. Furthermore, all patients were enrolled from a single site, and the natural course of the pleural effusions in these patients was not closely followed.

Click to read the article in the JCO (Journal of Clinical Oncology)

RELATED REPORTS

Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective

Optune Mya is not approved for brain metastases from non-small cell lung cancer in topline regulatory results

Relevant reading: The IASLC lung cancer stating project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors

FDA approvedFor non-small cell lung cancer: Jideytro (zidesamtinib), Jul 22, 2026→

In-Depth [retrospective cohort study]: This study included a cohort of 2061 patients diagnosed with stage I to IV NSCLC at a single university hospital. Patients who underwent non-contrast chest CT scans or who did not undergo brain imaging or whole-body bone scans were excluded. They were then sorted into three groups based on chest CT scans: no pleural effusion, minimal pleural effusion (<10mm thick), and malignant pleural effusion. No pleural fluid evaluation was done in the minimal pleural effusion group. Survival analysis was then performed, prognostic variables including patient demographics, weight loss prior to diagnosis, hematology studies, stage migration, tumor-related variables, and treatment-related variables. There were a total of 1397 patients without pleural effusion, 272 with minimal pleural effusion, and 392 with malignant pleural effusion. The authors found that minimal pleural effusion was significantly associated with shorter survival time compared to patients without pleural effusion (7.7 versus 17.7 months, P < 0.001), even after adjustment for other prognostic variables (HR 1.4, 95% CI 1.21-1.62). Minimal pleural effusion had a higher prognostic impact in early versus advanced stage disease (Pinteraction = 0.001). After analyzing the probable mechanisms of minimal effusion, pleural invasion or attachment as the cause was seen in 87.8% of patients and independently predicted worse survival (P = 0.03).

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: early stage diseaselung cancernon-small cell lung canceroncologypleural biopsypleural effusionsurvivalthoracentesis
Previous Post

Hydrus microstent increases outflow in cadaveric human eyes

Next Post

Multiple opioid prescriptions associated with higher hospital admissions

RelatedReports

Lung cancer immunotherapy collage: engraved lungs and trachea, a cluster of round immune cells and a folded surgical towel
Cardiology

Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective

November 19, 2026
Large cell carcinoma collage of an older man beside engraved lungs with a cobalt patch, a blank CT film and a potted fern
2MM Trial Briefs

Optune Mya is not approved for brain metastases from non-small cell lung cancer in topline regulatory results

November 12, 2026
Lung cancer collage: engraved lungs with the trachea and branching bronchi above a knitted wool scarf and a pine sprig
2MM Trial Briefs

Ivonescimab plus chemotherapy produced major and complete pathological responses in resectable NSCLC in a phase II study

November 6, 2026
Mitral valve prolapse collage of an engraved heart with a parachute-like valve, a stethoscope and a calm woman
Cardiology

Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation

October 31, 2026
Next Post

Multiple opioid prescriptions associated with higher hospital admissions

Transcatheter aortic valve replacement provides only minor benefit to quality of life

Transcatheter aortic valve replacement provides only minor benefit to quality of life

Smoking may not affect short-term outcomes in cranial surgery

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.